Status:
COMPLETED
Treatment of Obsessive Compulsive Disorder in Children
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Obsessive-Compulsive Disorder
Eligibility:
All Genders
7-17 years
Phase:
PHASE3
Brief Summary
This study will determine whether cognitive behavioral therapy delivered by either psychologists or psychiatrists can improve the effectiveness of serotonin reuptake inhibitor treatment in children wi...
Detailed Description
The vast majority of children with obsessive compulsive disorder (OCD) are given serotonin reuptake inhibitor (SRI) drugs as initial treatment. However, recommended doses of these medications leave ma...
Eligibility Criteria
Inclusion
- DSM-IV Diagnosis of obsessive compulsive disorder
- CYBOCS total score greater than 16
Exclusion
- Other primary or co-primary psychiatric disorder
- Pervasive developmental disorder or disorders, including Asperger's Syndrome
- Thought disorder
- Prior failed trial of cognitive-behavioral therapy
- Has pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS) or maintenance antibiotic for obsessive-compulsive disorder
- Mental retardation
- Pregnancy
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT00074815
Start Date
September 1 2003
End Date
November 1 2009
Last Update
July 29 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Child and Family Study Center
Durham, North Carolina, United States, 27705
2
University of Pennsylvania, The Center for the Treatment and Study of Anxiety
Philadelphia, Pennsylvania, United States, 19104
3
Rhode Island Hospital
Providence, Rhode Island, United States, 02903